Anesthesia Management in Moyamoya Disease
Anesthesia Management in Moyamoya Disease Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by the narrowing of the intracranial internal carotid arteries and their main branches. This constriction leads to the development of a fragile network of collateral vessels that resemble a “puff of smoke” on angiograms, which is the literal meaning of “moyamoya” in Japanese. Patients often present with ischemic strokes, transient ischemic attacks, or hemorrhages, making surgical intervention and meticulous anesthesia management crucial to prevent perioperative complications.
Anesthesia management in patients with moyamoya disease requires a comprehensive understanding of the pathophysiology and the delicate balance needed to maintain cerebral perfusion. The primary goal is to ensure adequate oxygenation and cerebral blood flow (CBF) while avoiding fluctuations that could precipitate ischemia or hemorrhage. Preoperative assessment includes detailed neurological evaluation, imaging studies, and evaluation of collateral circulation. Coexisting conditions such as hypertension, anemia, or coagulopathies also need to be stabilized before surgery. Anesthesia Management in Moyamoya Disease
Anesthesia Management in Moyamoya Disease Intraoperatively, maintaining hemodynamic stability is of utmost importance. Hypotension can diminish cerebral perfusion, especially in areas reliant on collateral vessels, increasing the risk of ischemic injury. Conversely, hypertension poses a risk of hemorrhage, particularly from fragile abnormal vessels. Anesthetic agents should be chosen to preserve cerebrovascular autoregulation. Volatile anesthetics like sevoflurane or desflurane are commonly used, but their doses should be titrated carefully. Total intravenous anesthesia (TIVA) with agents like propofol can offer better control over hemodynamics.
Monitoring techniques play a vital role. In addition to standard monitoring, cerebral oximetry—using near-infrared spectroscopy—can provide real-time data on regional cerebral oxygen saturation, helping anesthesiologists detect ischemic changes early. Invasive
arterial blood pressure monitoring is almost always indicated to allow precise blood pressure management.
The anesthesia team must vigilantly control factors that influence cerebral blood flow, such as carbon dioxide levels. Hypocapnia, caused by hyperventilation, leads to vasoconstriction and decreased CBF, risking ischemia. Therefore, maintaining normocapnia is essential. Adequate hydration preserves blood volume and viscosity, optimizing perfusion without causing volume overload. Anesthesia Management in Moyamoya Disease
Anesthesia Management in Moyamoya Disease Postoperative care involves close neurological monitoring for signs of ischemia or hemorrhage. Blood pressure should be carefully managed to avoid fluctuations. Pain control and sedation can help reduce metabolic demands and prevent agitation, which could otherwise compromise cerebral stability.
Anesthesia Management in Moyamoya Disease In conclusion, anesthesia management in moyamoya disease demands a tailored, vigilant approach that emphasizes hemodynamic stability, precise monitoring, and meticulous control of physiological parameters. This approach aims to minimize perioperative risks and promote favorable surgical outcomes, ensuring the best possible prognosis for these vulnerable patients.
